The mortality rate due to liver malignant neoplasms in Brazil among females demonstrates a steady rise from 5.1 thousand in 2024 to 5.5 thousand in 2028. Comparing this trend to actual data from 2023 could show potential changes. Year-on-year increases are constant at about 2%, indicating relative stability in the rising rate. Analyzing the data using a Compound Annual Growth Rate (CAGR) shows an average annual growth rate of around 2% over the five-year forecast period. This suggests a consistent and ongoing upward trend in mortality.
Future trends to watch for include potential impacts of healthcare advances, policy changes, or public health initiatives aimed at reducing liver cancer mortality rates. Attention should also be paid to developments in early detection technologies and treatments that could alter these forecasted trends.
